Amylyx Pharmaceuticals Co-CEO Justin B. Klee sells $2.98 million in common shares
AMLX•Amylyx Pharmaceuticals Co-CEO and director Justin B. Klee sold 100,000 common shares on November 9, 2026, for about $2.98 million. He retained direct ownership of 3,513,056 shares, according to a Form 4 dated November 12.
1. Share sale details
Klee sold 37,483 shares at $29.3917 each and another 62,517 shares at $30.1062 each on November 9. The Form 4 dated November 12 reported that he retained direct ownership of 3,513,056 common shares.
